Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, Dvorak V, Kim KH, Cestero RM, Berkovitch M, Ceyhan M, Ellison MC, Ritter MA, Yuan SS, DiNubile MJ, Saah AJ, Luxembourg A. Iversen OE, et al. Among authors: chokephaibulkit k. JAMA. 2016 Dec 13;316(22):2411-2421. doi: 10.1001/jama.2016.17615. JAMA. 2016. PMID: 27893068 Clinical Trial.
Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.
Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Sabchareon A, Pancharoen C, Bouckenooghe A, Gailhardou S, Boaz M, Feroldi E. Chokephaibulkit K, et al. Pediatr Infect Dis J. 2010 Dec;29(12):1111-7. doi: 10.1097/INF.0b013e3181f68e9c. Pediatr Infect Dis J. 2010. PMID: 20856164 Clinical Trial.
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.
Thisyakorn U, Chokephaibulkit K, Kosalaraksa P, Benjaponpitak S, Pancharoen C, Chuenkitmongkol S. Thisyakorn U, et al. Among authors: chokephaibulkit k. Hum Vaccin Immunother. 2014;10(7):1859-65. doi: 10.4161/hv.28642. Hum Vaccin Immunother. 2014. PMID: 25424793 Free PMC article. Clinical Trial.
Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
Sricharoenchai S, Lapphra K, Chuenkitmongkol S, Phongsamart W, Bouckenooghe A, Wittawatmongkol O, Rungmaitree S, Chokephaibulkit K. Sricharoenchai S, et al. Among authors: chokephaibulkit k. Pediatr Infect Dis J. 2017 Feb;36(2):e45-e47. doi: 10.1097/INF.0000000000001395. Pediatr Infect Dis J. 2017. PMID: 27846060 Clinical Trial.
Cohort profile: the TREAT Asia pediatric HIV observational database.
Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon P, Hansudewechakul R, Amin J, Kumarasamy N, Puthanakit T, Kurniati N, Nik Yusoff NK, Saphonn V, Fong SM, Razali K, Nallusamy R, Sohn AH, Sirisanthana V. Kariminia A, et al. Among authors: chokephaibulkit k. Int J Epidemiol. 2011 Feb;40(1):15-24. doi: 10.1093/ije/dyp358. Epub 2010 Jan 25. Int J Epidemiol. 2011. PMID: 20100820 Free PMC article. No abstract available.
321 results